Department of Endocrinology, Hospital Puerta del Mar, Cádiz, Spain.
Acta Diabetol. 2013 Apr;50(2):201-8. doi: 10.1007/s00592-011-0264-2. Epub 2011 Feb 17.
The relationship between late-onset gestational diabetes mellitus [GDM] and oxidative stress is not well known, and the importance of the oxidant/antioxidant equilibrium in the clinical evolution and its complications require elucidation. The aim of the study was to evaluate the relationships between maternal levels of markers of oxidative stress in women with late-onset GDM that, potentially, may have considerable clinical implications in the pathogenesis and/or the evolution of GDM. Pregnant women (n = 78; 53 with GDM, 25 controls), between the 24th and 29th week of gestation, were enrolled. Both groups were analysed for demographic data, perinatal and obstetrics outcomes together with the levels of the marker's oxidative stress and antioxidant status. Control versus patient results in the univariate analysis were the following: pre-gestational body mass index [BMI] 23.31 ± 4.2 vs. 27.13 ± 4.6 kg/m(2) (P = 0.001); weeks at delivery 39.2 ± 3.05 vs. 38.9 ± 1.8 (P = 0.09); Caesarean delivery 12.5 vs. 43% (P = 0.004); macrosomia 4 vs. 9.4% (P = 0.6); lipoperoxides [LPO] 2.06 ± 1.00 vs. 3.14 ± 1.55 μmol/mg (P = 0.001); catalase 3.23 ± 1.41 vs. 2.52 ± 1.3 nmol/min/ml (P = 0.03); superoxide dismutase [SOD] 0.11 ± 0.04 vs. 0.08 ± 0.01 U/ml (P = 0.0003); glutathione peroxidase [GPX] 0.03 ± 0.006 vs. 0.025 ± 0.006 nmol/min/ml (P = 0.01); glutathione reductase [GSH] 0.004 ± 0.002 vs. 0.004 ± 0.004 nmol/min/ml (P = 0.9)]; and glutathione transferase [GST] 0.0025 ± 0.0012 vs. 0.0027 ± 0.00017 nmol/min/ml (P = 0.7). Multivariate analysis showed catalase might have a protective effect against GDM development and LPO seems to be a risk factor for the disease. These data suggest an increase in oxidative stress and a decrease in antioxidative defence in women with late-onset GDM and, as such, may have considerable clinical implications in the pathogenesis and/or the course of the pregnancy in these patients.
晚发型妊娠期糖尿病[GDM]与氧化应激之间的关系尚不清楚,氧化应激/抗氧化平衡在临床演变及其并发症中的重要性需要阐明。本研究旨在评估晚发型 GDM 患者体内氧化应激标志物水平之间的关系,这些标志物可能在 GDM 的发病机制和/或演变中具有重要的临床意义。在妊娠 24 至 29 周时,共纳入了 78 名孕妇(53 名 GDM 患者,25 名对照组)。对两组的人口统计学数据、围产期和产科结局以及氧化应激和抗氧化状态标志物的水平进行了分析。单因素分析中对照组与患者组的结果如下:孕前体重指数[BMI]23.31±4.2 与 27.13±4.6 kg/m2(P=0.001);分娩时的周数 39.2±3.05 与 38.9±1.8(P=0.09);剖宫产 12.5%与 43%(P=0.004);巨大儿 4%与 9.4%(P=0.6);脂质过氧化物[LPO]2.06±1.00 与 3.14±1.55 μmol/mg(P=0.001);过氧化氢酶 3.23±1.41 与 2.52±1.3 nmol/min/ml(P=0.03);超氧化物歧化酶[SOD]0.11±0.04 与 0.08±0.01 U/ml(P=0.0003);谷胱甘肽过氧化物酶[GPX]0.03±0.006 与 0.025±0.006 nmol/min/ml(P=0.01);谷胱甘肽还原酶[GSH]0.004±0.002 与 0.004±0.004 nmol/min/ml(P=0.9)];和谷胱甘肽转移酶[GST]0.0025±0.0012 与 0.0027±0.00017 nmol/min/ml(P=0.7)。多因素分析显示,过氧化氢酶可能对 GDM 的发生有保护作用,而 LPO 似乎是该病的危险因素。这些数据表明,晚发型 GDM 患者体内氧化应激增加,抗氧化防御能力降低,因此在这些患者的发病机制和/或妊娠过程中可能具有重要的临床意义。